Rchr
J-GLOBAL ID:201801020157195408   Update date: Sep. 18, 2024

matsushita makoto

マツシタ マコト | matsushita makoto
Affiliation and department:
Research field  (1): Tumor diagnostics and therapeutics
Research keywords  (1): 泌尿器科学
Research theme for competitive and other funds  (3):
  • 2022 - 2026 遺伝的素因、生活習慣、腸内細菌叢の多面的解析に基づく前立腺癌の早期診断戦略の構築
  • 2021 - 2024 腸内細菌叢が前立腺癌の進展に与える影響とそのメカニズムの解明
  • 2019 - 2022 Treatment approach through clarification of the mechanisms of immune cell- cytokine network in prostate cancer
Papers (110):
  • Chisato Wakamori, Marco A De Velasco, Kazuko Sakai, Yurie Kura, Makoto Matsushita, Saizo Fujimoto, Koji Hatano, Norio Nonomura, Kazutoshi Fujita, Kazuto Nishio, et al. A cross-species analysis of fecal microbiomes in humans and mice reveals similarities and dissimilarities associated with prostate cancer risk. The Prostate. 2024
  • 松下 慎, 藤田 和利, 林 拓自, 香山 尚子, 元岡 大祐, 長谷 拓明, 山本 顕生, 植村 俊彦, 山道 岳, 冨山 栄輔, et al. 高脂肪食によるディスバイオシスが前立腺癌に及ぼす影響の解明. 泌尿器外科. 2023. 36. 8. 895-896
  • Makoto Matsushita, Kazutoshi Fujita, Koji Hatano, Marco A De Velasco, Akira Tsujimura, Hirotsugu Uemura, Norio Nonomura. Emerging Relationship between the Gut Microbiome and Prostate Cancer. The world journal of men's health. 2023
  • Kazutoshi Fujita, Makoto Matsushita, Marco A De Velasco, Koji Hatano, Takafumi Minami, Norio Nonomura, Hirotsugu Uemura. The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome. Cancers. 2023. 15. 5
  • Yoshiyuki Yamamoto, Atsunari Kawashima, Toshitaka Morishima, Toshihiro Uemura, Akinaru Yamamoto, Gaku Yamamichi, Eisuke Tomiyama, Makoto Matsushita, Taigo Kato, Koji Hatano, et al. Comparative effectiveness of radiation versus radical cystectomy for localized muscle-invasive bladder cancer. Advances in Radiation Oncology. 2022. 101157-101157
more...
MISC (22):
  • 山本顕生, 河嶋厚成, 奥田洋平, 岡利樹, 植村俊彦, 中野剛佑, 松下慎, 石津谷祐, 山本致之, 加藤大悟, et al. Establishment of a novel mouse model in carcinogenesis of upper tract urothelial carcinoma. 日本泌尿器科学会総会(Web). 2023. 110th
  • Taigo Kato, Kazuma Kiyotani, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Koji Hatano, Atsunari Kawashima, et al. Early dynamics of T cell clonotypes as potential surrogate biomarker for immune checkpoint inhibitors. CANCER SCIENCE. 2022. 113
  • Taigo Kato, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Yujiro Hayashi, Kosuke Nakano, Yu Ishizuya, Cong Wang, Koji Hatano, Atsunari Kawashima, et al. T cell receptor sequencing predict early response for immune-check point inhibitors in urological cancer. CANCER SCIENCE. 2021. 112. 398-398
  • 松下慎, 藤田和利, 藤田和利, 林拓自, 香山尚子, 元岡大祐, 長谷拓明, 神宮司健太郎, 山道岳, 弓場覚, et al. 高脂肪食摂取前立腺癌マウスモデルを用いた腸内細菌による代謝産物を介した癌増殖メカニズムの解明. 日本アンドロロジー学会総会記事. 2021. 40th
  • Taigo Kato, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Kosuke Nakano, Yujiro Hayashi, Cong Wang, Yu Ishizuya, Koji Hatano, Takeshi Ujike, et al. IDENTIFICATION OF EARLY PREDICTIVE BIOMARKER FOR IMMUNE CHECKPOINT INHIBITORS BY T CELL RECEPTOR REPERTOIRE ANALYSIS IN ADVANCED KIDNEY CANCER PATIENTS. JOURNAL OF UROLOGY. 2020. 203. E234-E234
more...
Education (1):
  • 2004 - 2010 OSAKA UNIVERSITY School of Medicine Department of Medicine
Work history (4):
  • 2018/04 - 現在 OSAKA UNIVERSITY Graduate School of Medicine Department of Urology M.D
  • 2015/04 - 2018/03 Sumitomo Hospital Department of Urology M.D
  • 2014/04 - 2015/03 Ikeda Municipal Hospital Department of Urology M.D
  • 2010/04 - 2014/03 Osaka Rosai Hospital Department of Urology M.D
Association Membership(s) (5):
THE JAPANESE CANCER ASSOCIATION ,  Japan Society of Urologic Oncology ,  JAPAN SOCIETY OF CLINICAL ONCOLOGY ,  JAPANESE SOCIETY OF ENDOUROLOGY ,  THE JAPANESE UROLOGICAL ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page